Company intelligence / Profile preview

Scranton Enterprises

Amsterdam, Netherlands

Ownership: Private
Development stage: Other

Overview

Scranton Enterprises B.V. is a holding and investment company closely linked to the Grifols family, with large-scale interests in the plasma collection sector and a record of building leading bioscience businesses. It owns major assets in plasma collection and provides financial/structural support to healthcare operations like Scranton Plasma, Haema, and Biotest US, in direct partnership with Grifols.

Industry: Investors

Partnerships

Grifols

Beyond the preview

Go deeper on Scranton Enterprises.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scranton Enterprises.

Explore the full profile